Unintended consequences of the FDA’s e-cigarette regulations

Status
Not open for further replies.

xhuffer

Senior Member
ECF Veteran
Oct 21, 2011
142
173
SoCal
A well written article by Christopher Russell.

What, then, will people who currently use e-cigarettes do if, on August 8th 2018, their preferred products are no longer legally available to buy. My research team at the Centre for Substance Use Research (CSUR) recently asked this question to more than 9,000 US-based e-cigarette users, and the results should give FDA cause for alarm.

First, 8,451 current e-cigarette users who were also former cigarette smokers were asked what they would likely do if, as a consequence of the Deeming Rule, the e-cigarette products they use right now were taken off the market. Approximately 73 percent of the vaping former smokers indicated they would ‘bulk buy’/stock up on their preferred products before the rule was implemented.

Unintended consequences of the FDA’s e-cigarette regulations
 

BuGlen

Divergent
Supporting Member
ECF Veteran
Mar 6, 2012
1,952
3,976
Tampa, Florida
It was a decent article, right up to about this statement:

We also do not question that FDA is sincere in its efforts to protect and improve and protect the health of Americans. But the evidence from our study is clear: the deeming regulations, if implemented as they are currently written, rationalize several behaviors that would significantly increase e-cigarette users risk for ill health.

My response:

While, years ago, the FDA may have been founded with the intent to protect the public health, it has been decades since that mandate has been the real goal. In more recent years, the FDA has almost exclusively served as a "pay to play" gateway for huge multi-national drug manufacturers, making it nearly impossible for smaller and more innovative labs to test and market their drugs. Very recently, the former commissioner of the FDA was charged with racketeering and colluding to conceal serious drug issues. Yet you do not question the intent of this organization, even though the new commissioner and other leaders within all come from the big pharma industry.

Really?
 
Status
Not open for further replies.

Users who are viewing this thread